Article
Treatment with direct-acting antiviral agents of hepatitis C virus infection in injecting drug users: A prospective study.
Journal of viral hepatitis - 1 Oct 2017
Boglione L, Mornese Pinna S, De Nicolò A, Cusato J, Cariti G, Di Perri G, D'Avolio A
Abstract excerpt
In this prospective study, we evaluated the effectiveness and tolerability of novel therapies against hepatitis C virus (HCV) in a cohort of PWID enrolled at our centre from April 2015 to July 2016. In this analysis, a total of 174 patients were included: eleven (6.3%) were treated with pegylated interferon (PEG-IFN) and ribavirin (RBV) containing regimens, 163 (93.7%) with IFN-free treatments. RBV has been used...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
